A randomised trial to see if closing the arterial duct improves outcome in very premature babies

Phase 2

Recruiting

• Conditions: Premature babies; Patent ductus arteriosus; Death; Chronic lung disease; Reproductive Health and Childbirth - Complications of newborn; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system

• Registration Number: ACTRN12607000532404
• Lead Sponsor: Dr David Knight

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-10-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Birthweight <1250g or gestational age <28 weeks. Large patent ductus arterisous diagnosed by echocardiography at 3 days of age.

Exclusion Criteria

Significant congenital anomalies, likely death within hours, previous indomethacin, contraindication to indomethacin.

Study & Design

• Study Type: Interventional
• Study Design: Not specified